Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page
- Check5 days agoChange DetectedThe study record now shows a completed status with updated timestamps marking the end of the trial's lifecycle; the former recruiting indicator and associated dates were removed to reflect that recruitment is finished and results may be posted.SummaryDifference0.1%

- Check12 days agoChange DetectedTaoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the locations list, updating the Taiwan study site address to reflect the correct city designation. This refines the site data to help participants identify and navigate to the correct study location.SummaryDifference0.0%

- Check19 days agoChange DetectedThe study’s listed site locations were updated by switching between region-name variants (Spanish/Czech administrative region wording) and adding the simplified versions for certain Chile and Czechia entries. Separately, the page revision/version string was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.3%

- Check26 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2. This appears to be a minor software version update with no visible changes to the study details.SummaryDifference0.0%

- Check33 days agoChange DetectedPadua has been replaced with Padova (35128) as the Veneto site name. Padova is now listed as the site location.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Naples, Italy 80131 to the locations and removed Napoli, Italy 80131 from the locations.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.